Key Influencers & Advisors

Martin Yaffe

Ph.D., Senior Advisor

Dr. Yaffe is currently a senior scientist in physical sciences at Odette Cancer Research Program, Sunnybrooke Research Institute in Toronto, Ontario.

Read More

Karen K Lindfors

M.D., MPH, FACR, Senior Advisor

Dr. Lindfors is a leading expert in the field of breast cancer screening and breast imaging and diagnostics, having specialized in cancer radiology and breast imaging and diagnostics radiology for more than 30 years.

Read More

Norbert Pelc

Ph.D., Senior Development and Technology Advisor

Dr. Pelc is a professor of bioengineering and radiology at Stanford University, and served as chair of the university’s department of bioengineering from 2012 to 2017.

Read More

Craig Shimasaki

Ph.D., MBA, Medical Device Business Consultant

Dr. Shimasaki has 35 years of biotechnology industry experience and co-founded nine companies, five which were taken public. He is President and CEO of Moleculera Labs and BioSource Consulting.

Read More

John McGraw

MSc, Ph.D, Executive Vice President of Commercial Operations

Dr. McGraw has 21 years experience in heath care business development and has created and implemented successful strategies for the advancement clinical trials and medical device development through licensing and acquisitions.

Read More

George Burkett

M. Eng, Advisor

Mr. Burkett holds a Master’s Degree in Mechanical and Aeronautical Engineering and has spent the last 15 years working at UC Davis. He is credited for his crucial role in the detailed design and the mechanical and hardware development of breast CT.

Read More

Anita Nosratieh

Ph.D, FDA Advisor

Dr. Nosratieh was a lead reviewer with the FDA where she worked with companies seeking approval of breast cancer screening and diagnostic devices. As lead reviewer, she gained first-hand knowledge of the standards and practices companies need to make it through the early stage development process to regulatory approval.

Read More

Craig Abbey

Ph.D, Advisor

Dr. Abbey has served as a Scientific Reviewer for the FDA where he sat on independent review panels to evaluate reader studies proposed by companies seeking FDA approval of medical imaging devices including Hologic’s Digital Breast Tomosynthesis

Read More